Research Corporation Technologies (RCT) is a technology investment and management company that provides early-stage funding and development for promising biomedical companies and technologies. RCT's strategy focuses on innovations originating from universities and research institutions worldwide, with a primary interest in biotechnology therapeutics and tools, and medical devices.
100% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-b (50% of deals).
Portfolio
2
Fund Size
$500M
Top Stage
Series B
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
2 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Pheon Therapeutics | Series B | $120M | May 2024 |
| Pheon Therapeutics | Series A | $68M | Sep 2022 |
Top Co-Investors
Atlas Venture2 shared
Brandon Capital2 shared
Forbion2 shared
Lightspeed Venture Partners1 shared
BVF Partners LP1 shared
Perceptive Advisors1 shared
Last updated: 28 April 2026